Literature DB >> 26318559

Surface Charge Measurement of SonoVue, Definity and Optison: A Comparison of Laser Doppler Electrophoresis and Micro-Electrophoresis.

Fairuzeta Ja'afar1, Chee Hau Leow2, Valeria Garbin3, Charles A Sennoga4, Meng-Xing Tang5, John M Seddon1.   

Abstract

Microbubble (MB) contrast-enhanced ultrasonography is a promising tool for targeted molecular imaging. It is important to determine the MB surface charge accurately as it affects the MB interactions with cell membranes. In this article, we report the surface charge measurement of SonoVue, Definity and Optison. We compare the performance of the widely used laser Doppler electrophoresis with an in-house micro-electrophoresis system. By optically tracking MB electrophoretic velocity in a microchannel, we determined the zeta potentials of MB samples. Using micro-electrophoresis, we obtained zeta potential values for SonoVue, Definity and Optison of -28.3, -4.2 and -9.5 mV, with relative standard deviations of 5%, 48% and 8%, respectively. In comparison, laser Doppler electrophoresis gave -8.7, +0.7 and +15.8 mV with relative standard deviations of 330%, 29,000% and 130%, respectively. We found that the reliability of laser Doppler electrophoresis is compromised by MB buoyancy. Micro-electrophoresis determined zeta potential values with a 10-fold improvement in relative standard deviation.
Copyright © 2015 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Keywords:  Definity; Laser Doppler electrophoresis; Micro-electrophoresis; Microbubbles; Optison; Particle tracking; SonoVue; Surface charge; Ultrasound contrast agents; Zeta potential

Mesh:

Substances:

Year:  2015        PMID: 26318559     DOI: 10.1016/j.ultrasmedbio.2015.07.001

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  8 in total

Review 1.  Reverse engineering the ultrasound contrast agent.

Authors:  Mark A Borden; Kang-Ho Song
Journal:  Adv Colloid Interface Sci       Date:  2018-10-24       Impact factor: 12.984

Review 2.  Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Authors:  Scott Schoen; M Sait Kilinc; Hohyun Lee; Yutong Guo; F Levent Degertekin; Graeme F Woodworth; Costas Arvanitis
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

3.  Ultrasound Assisted a Peroxisome Proliferator-Activated Receptor (PPAR)γ Agonist-Loaded Nanoparticle-Microbubble Complex to Attenuate Renal Interstitial Fibrosis.

Authors:  Shuping Wei; Chaoli Xu; Yidan Zhang; Zhongqing Shi; Min Wu; Bin Yang
Journal:  Int J Nanomedicine       Date:  2020-10-02

Review 4.  Nanomaterials as Ultrasound Theragnostic Tools for Heart Disease Treatment/Diagnosis.

Authors:  Edouard Alphandéry
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 5.  A Quality by Design Approach in Pharmaceutical Development of Non-Viral Vectors with a Focus on miRNA.

Authors:  Ioana Toma; Alina Silvia Porfire; Lucia Ruxandra Tefas; Ioana Berindan-Neagoe; Ioan Tomuță
Journal:  Pharmaceutics       Date:  2022-07-16       Impact factor: 6.525

6.  Ultrasound Microbubbles Enhance the Efficacy of Insulin-Like Growth Factor-1 Therapy for the Treatment of Noise-Induced Hearing Loss.

Authors:  Yi-Chun Lin; Yuan-Yung Lin; Hsin-Chien Chen; Chao-Yin Kuo; Ai-Ho Liao; Ying-Liang Chou; Chia-Lien Hung; Cheng-Ping Shih; Chih-Hung Wang
Journal:  Molecules       Date:  2021-06-13       Impact factor: 4.411

7.  Static Magnetic Fields Dampen Focused Ultrasound-mediated Blood-Brain Barrier Opening.

Authors:  Yaoheng Yang; Christopher Pham Pacia; Dezhuang Ye; Yimei Yue; Chih-Yen Chien; Hong Chen
Journal:  Radiology       Date:  2021-07-06       Impact factor: 29.146

8.  Ultrasound- and Microbubble-Assisted Gemcitabine Delivery to Pancreatic Cancer Cells.

Authors:  Tormod Bjånes; Spiros Kotopoulis; Elisa Thodesen Murvold; Tina Kamčeva; Bjørn Tore Gjertsen; Odd Helge Gilja; Jan Schjøtt; Bettina Riedel; Emmet McCormack
Journal:  Pharmaceutics       Date:  2020-02-07       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.